Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Charles River agrees $470m deal for Frontage assets

Nov 10, 2026, 9:41 AM

Read Full Article → Charles River agrees $470m deal for Frontage assets

Charles River agrees $470m deal for Frontage assets

Translate article text

Choose a language and wait for the translated text.

CRL has signed definitive agreements to acquire Frontage’s bioanalysis and DMPK operations in Exton, Pennsylvania for roughly $470m in cash.

Charles River agrees $470m deal for Frontage assets | PharmaVoice